购物车
- 全部删除
- 您的购物车当前为空
RPS6-IN-1(Compound 22o)通过抑制细胞转移和诱导细胞凋亡(Apoptosis),增强Bax、p53、cleaved-caspase 3及cleaved-PARP的表达,从而发挥其抗癌效果.此外,RPS6-IN-1还能降低线粒体膜电位,并且通过PI3K-Akt-mTOR信号通路激活自噬(Autophagy),对细胞内的线粒体和溶酶体造成损伤,引起内质网应激.同时,这种化合物抑制RPS6的磷酸化,表现出较低的全身毒性,是一种有效的抗化合物.
RPS6-IN-1(Compound 22o)通过抑制细胞转移和诱导细胞凋亡(Apoptosis),增强Bax、p53、cleaved-caspase 3及cleaved-PARP的表达,从而发挥其抗癌效果.此外,RPS6-IN-1还能降低线粒体膜电位,并且通过PI3K-Akt-mTOR信号通路激活自噬(Autophagy),对细胞内的线粒体和溶酶体造成损伤,引起内质网应激.同时,这种化合物抑制RPS6的磷酸化,表现出较低的全身毒性,是一种有效的抗化合物.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | RPS6-IN-1 (Compound 22o) inhibits cell migration and induces apoptosis (increasing the expression of Bax, p53, cleaved-caspase 3, and cleaved-PARP). It reduces mitochondrial membrane potential and activates autophagy (Autophagy) through the PI3K-Akt-mTOR signaling pathway, damaging mitochondria and lysosomes within the cell and causing endoplasmic reticulum stress. RPS6-IN-1 also inhibits the phosphorylation of RPS6. Notably, RPS6-IN-1 is a low systemic toxicity anticancer agent. |
体外活性 | RPS6-IN-1 对多种癌细胞系显示出显著的抑制增殖效果,其IC 50 值涵盖:HCT-116细胞系为3.82 μM,HeLa细胞系为2.80 μM,MCF-7细胞系为5.54 μM,A549细胞系为45.96 μM,HepG2细胞系为32.71 μM,PANC-1细胞系为13.02 μM. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容